Advanced search
Publication Cover
Journal of Cosmetic and Laser Therapy Volume 12, 2010 - Issue 2
Submit an article Journal homepage
331
Views
29
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines

Nicholas J. Lowe Cranley Clinic, London, UK; Clinical Research Specialists, London, UK and Santa Monica, CA, USA; UCLA School of Medicine, Los Angeles, CA, USACorrespondence[email protected]
,
Aadarsh Shah Cranley Clinic, London, UK; Clinical Research Specialists, London, UK and Santa Monica, CA, USA
,
Philippa L. Lowe Cranley Clinic, London, UK; Clinical Research Specialists, London, UK and Santa Monica, CA, USA
&
Rickie Patnaik Clinical Research Specialists, London, UK and Santa Monica, CA, USA
Pages 106-111 | Received 27 Jul 2009, Accepted 04 Nov 2009, Published online: 12 Feb 2010

References

  • Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol. 1973;12:924–7.
  • Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980; 87:1044–9.
  • Keen M, Blitzer A, Aviv J, Binder W, Prystowsky J, Smith H, . Botulinum toxin A for hyperkinetic facial lines: Results of a double blind, placebo controlled study. Plast Reconstr Surg. 1994;94:94–9.
  • Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol. 1996;35:569–72.
  • Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, . Botox Glabellar Lines I Study Group: A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002; 46:840–9.
  • Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N, . Double-blind, randomized, placebo-controlled, dose–response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg. 2005;31:257–62.
  • Flynn TC, Carruthers JA, Carruthers JA, Clark RE 2nd. Botulinum A toxin (BOTOX) in the lower eyelid: Dose-finding study. Dermatol Surg. 2003;29:943–50.
  • Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Moore D. Botulinum toxins types A and B for brow furrows: Preliminary experiences with type B toxin dosing. J Cosmet Laser Ther. 2002;4:15–18.
  • Heckmann M, Plewig G, Hyperhidrosis Study Group. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: A randomized, side-by-side, open-label study. Arch Dermatol. 2005;141:1255–9.
  • Wohlfarth K, Goschel H, Frevert J, Dengler R, Bigalke H. Botulinum A toxins: Units versus units. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:335–40.
  • Durif F. Clinical bioequivalence of the current commercial preparations of botulinum toxin. Eur J Neurol. 1995;2:17–18.
  • Sampaio C, Costa J, Ferreira JJ. Clinical comparability of marketed formulations of botulinum toxin. Mov Disord. 2004;19:129–36.
  • Lowe P, Patnaik R, Lowe N. Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: A double-blind, randomized study. J Am Acad Dermatol. 2006;55:975–80.
  • Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol. 2002;47:834–40.
  • Trindade de Almeida AR, Marques E, de Almeida J, Cunha T, Boraso R. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg. 2007;33:37–43.
  • Cliff SH, Judodihardjo H, Eltringham E. Different formulations of botulinum toxin type A have different migration characteristics: A double-blind, randomized study. J Cosmet Dermatol. 2008;7:50–4.
  • Carruthers A, Carruthers J, Hardas B, Kaur M, Goertelmeyer R, Jones D, . A validated grading scale for crow's feet. Dermatol Surg. 2008;34(suppl 2):S173–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.